CSE Bulletin: Consolidation - Mydecine Innovations Group Inc. (MYCO)
Newsfile·2025-10-20 21:39
Toronto, Ontario--(Newsfile Corp. - Le 20 octobre/October 2025) - Mydecine Innovations Group Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every fifty (50) pre-consolidated common shares. As a result, the number of outstanding shares will be reduced to approximately 1,235,107 common shares. The name and symbol will not change. Please note that all open orders will be canceled at the close of business on Octobe ...